BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,281,000 | +16.9% | 100,000 | 0.0% | 0.23% | +28.5% |
| Q2 2021 | $8,796,000 | -79.5% | 100,000 | -81.8% | 0.18% | -85.1% |
| Q2 2020 | $42,900,000 | +22.3% | 550,000 | -8.3% | 1.20% | -19.1% |
| Q1 2020 | $35,088,000 | -12.4% | 600,000 | +20.0% | 1.48% | -4.1% |
| Q4 2019 | $40,055,000 | -9.1% | 500,000 | -16.7% | 1.55% | -12.5% |
| Q3 2019 | $44,082,000 | -37.7% | 600,000 | -20.0% | 1.77% | -38.2% |
| Q2 2019 | $70,748,000 | +4.0% | 750,000 | -11.8% | 2.86% | +3.0% |
| Q1 2019 | $68,043,000 | +110.4% | 850,000 | +41.7% | 2.78% | +131.9% |
| Q4 2018 | $32,346,000 | -17.1% | 600,000 | +20.0% | 1.20% | +18.0% |
| Q3 2018 | $39,030,000 | -31.7% | 500,000 | -44.4% | 1.02% | -16.4% |
| Q2 2018 | $57,132,000 | +24.6% | 900,000 | +80.0% | 1.21% | +111.9% |
| Q1 2018 | $45,850,000 | +508.0% | 500,000 | +400.0% | 0.57% | +402.6% |
| Q4 2017 | $7,541,000 | – | 100,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |